Incidence of Pulmonary Hypertension in Correlation to Chest Computed Tomography Scan Findings in Post Covid Fibrosis | ||||
| Al-Azhar International Medical Journal | ||||
| Volume 2025, Issue 1, January 2025 | ||||
| DOI: 10.58675/2682-339X.2860 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
| Hussein Abualyazid1; Abdullah Suliman1; Ahmed Abdo2; Eslam Algaml1 | ||||
| 1Chest Diseases, Faculty of Medicine for Boys, Al-Azhar University, Cairo, Egypt | ||||
| 2Cardiology, Faculty of Medicine for Boys, Al-Azhar University, Cairo, Egypt | ||||
| Abstract | ||||
| Background: Coronavirus disease 2019 (COVID-19) is a worldwide pandemic that developed from SARS-CoV-2, a coronavirus that causes severe acute respiratory syndrome and is marked by extensive lung involvement. Aim and objectives: To assess the incidence and severity of pulmonary hypertension (PH) in healthy individuals nine months following the resolution of a mild to moderate COVID-19 infection in the lungs. Patients and methods: In this prospective investigation, 70 patients with mild to moderate COVID-19 lung infections were evaluated at AL-Hussein and Bab El-Sharia (Saied Galal) Hospitals. Results: Both the normal and high-pressure groups had mean tricuspid annular plane systolic excursions (TAPSE) of 25.8±2.4mm and 17.2±3.2mm, respectively. The average strain in the normal pressure group was -19.3±2.3% RV-GLS, while in the high-pressure group it was -26.7±3.1%. An independent sample t-test (P<0.001) revealed a statistically significant distinction between the groups with respect to TAPSE and RV-GLS. Conclusion: Even in cases of minor pneumonia, pulmonary hypertension is a common consequence of COVID-19. Although its historical development is still up in the air, its longevity appears to be underappreciated. Both the initial pulmonary injury's severity and the inflammatory response's magnitude seem to play a role. | ||||
|
Statistics Article View: 14 |
||||
